SCHEMBL23352152

SCHEMBL23352152

O=[SH](=O)c1c(Cl)cc(C(F)(F)F)cc1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.41
HPGD P15428 2/20 0.41
CYP3A4 P08684 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
HIF1A Q16665 1/20 0.41
TXNRD1 Q16881 1/20 0.41
TXNRD3 Q86VQ6 1/20 0.41
TXNRD2 Q9NNW7 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
CES2 O00748 1/20 0.38
PDE2A O00408 1/20 0.37
GPR35 Q9HC97 2/20 0.36
MAPT P10636 3/20 0.36
GABRA2 P47869 2/20 0.36
GABRB2 P47870 2/20 0.36
GABRP O00591 1/20 0.36
GABRD O14764 1/20 0.36
GABRA1 P14867 1/20 0.36
GABRB1 P18505 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24793523 0.76 CES2 (0.41) ALDH1A1HPGDCYP3A4ALOX15TSHR
SCHEMBL5600046 0.75 ALDH1A1 (0.43) ALDH1A1HPGDCYP3A4ALOX15TSHR
SCHEMBL981089 0.74 ALDH1A1 (0.46) ALDH1A1HPGDCYP3A4ALOX15TSHR
SCHEMBL15850522 0.72 PDE2A (0.41) ALDH1A1HPGDCYP3A4ALOX15TSHR
SCHEMBL22366856 0.72 GABRB3 (0.44) ALDH1A1HPGDCYP3A4ALOX15TSHR
SCHEMBL668872 0.72 PDE2A (0.41) ALDH1A1HPGDCYP3A4ALOX15TSHR
SCHEMBL17351793 0.71 ALDH1A1 (0.49) ALDH1A1HPGDTDP1MAPTKDM4E
SCHEMBL28061070 0.71 ALDH1A1 (0.47) ALDH1A1HPGDCYP3A4ALOX15TSHR
SCHEMBL967220 0.70 ALDH1A1 (0.50) ALDH1A1HPGDCYP3A4ALOX15TSHR
SCHEMBL25374080 0.70 PDE2A (0.39) ALDH1A1HPGDCYP3A4ALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210139521-A1 DIARYL TREHALOSE COMPOUNDS AND USES THEREOF THE UNIV OF MONTANA (US) 2021-05-13 US disclosed
CN-101273019-A Novel benzimidazole and benzothiazole derivatives, method for preparing same, use thereof as drugs, pharmaceutical compositions and novel use especially as C-Met inhibitors AVENTIS PHARMA SA (FR) 2008-09-24 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210139521-A1 DIARYL TREHALOSE COMPOUNDS AND USES THEREOF TREH, STT3B, DDOST ALDH1A1 3190/4885HPGD 2223/4885CYP3A4 4494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.